CLEER THE AIR

Discussing the science behind Cleerly's new standard of care for heart disease.

precision heart care

4 min read

Atherosclerosis Treatment Algorithms for Heart Disease Evaluation

Quantification of coronary artery disease (CAD) burden and atherosclerotic plaque type has been shown to be the strongest determinant of future risk of major adverse cardiac events (MACE).1 Until recently, though, there had been no clinically useful...

Read More »

4 min read

Understanding Your Heart Disease Risk

Heart disease is the cause of death for 700,000 Americans1 and nearly 17.9 million people worldwide every year.2 While some of these individuals likely had indicators for higher risk, such as high cholesterol or high blood pressure, studies show that up...

Read More »

4 min read

Cleerly Value to Health Systems: Precision Heart Care Reduces Risk and Improves Patient Care

Current methodologies for coronary artery disease (CAD) screening often result in misidentification of low-risk patients and may submit patients to unnecessary and expensive invasive procedures.

Cleerly’s coronary computed tomography angiography...

Read More »

2 min read

Cleerly Value to Health Plans: Precision Heart Care Reduces Waste and Improves Patient Experience

Cleerly is making the future of cardiovascular care possible through easy-to-use, clinically proven technology that effortlessly integrates into provider workflows and patient care journeys.

Our personalized care pathway for heart attack prevention...

Read More »

3 min read

Cleerly Value to Private Practice: Precision Heart Care Allows for Personalized Heart Disease Evaluation

Current methodologies for screening for coronary artery disease (CAD) at the primary care provider’s office are often limited. And once heart disease is suspected or identified by these methods, patients must often be referred to a specialist for...

Read More »

2 min read

What to Expect with a CCTA Scan

Cleerly makes early detection of heart disease risk possible through our AI-enabled analysis of coronary computed tomography angiography (CCTA) imaging that guides physicians towards creating personalized and preventive treatment plans for patients. To...

Read More »

3 min read

Catching Plaque Early Guides Personalized Treatment and Tracking of Heart Disease

Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care that emphasizes comprehensive evaluation of atherosclerotic plaque for guiding personalized treatment and tracking heart disease over time...

Read More »

3 min read

How Cleerly Outperforms Stress Tests

Myocardial perfusion, also known as a "stress test", is today's go-to-method for detecting coronary artery disease - despite limited performance.

Read More »

7 min read

Cleerly Personalized Care Pathway is Transforming Heart Health

The current approach to cardiovascular care is flawed for two reasons. One is the lack of a disease-based care paradigm with a focus on actual heart disease–atherosclerosis– in lieu of an emphasis on symptom-driven care that identifies only late-stage...

Read More »

3 min read

SCCT 2022: Defining the Future of Cardiovascular CT

Last week, our team at Cleerly had the opportunity to take part in a gathering of impassioned cardiac computed tomography (CT) leaders at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Las Vegas. As the former...

Read More »